Get 40% Off
🚨 Volatile Markets? Find Hidden Gems for Serious OutperformanceFind Stocks Now

Venezuela's Maduro receives first dose of Sputnik V coronavirus vaccine

Published 03/06/2021, 01:59 PM
Updated 03/06/2021, 02:01 PM
© Reuters. Venezuela's President Maduro receives COVID-19 vaccine in Caracas

CARACAS (Reuters) - Venezuelan President Nicolas Maduro and first lady Cilia Flores have received their first dose of Russia's Sputnik V coronavirus vaccine, Venezuelan state television reported on Saturday, while the country received a second shipment of the vaccine.

Images of both Maduro and Flores receiving their doses were broadcast on state television. Maduro said he felt "fine" after receiving the injection.

"Across the world the studies say that the Russian vaccine is a great vaccine to generate immunity," Maduro said. "We will guarantee all vaccines for the people of Venezuela."

Later on Saturday, Venezuela's Health Ministry said the second batch of 100,000 Sputnik V doses had arrived from Moscow via a flight operated by state airline Conviasa.

Venezuela had received the first 100,000 doses of the Sputnik V vaccine on Feb. 13. Maduro said authorities had administered around 60% of those doses, prioritizing medical personnel as well as officials and lawmakers in the first phase.

The South American country, home to some 25 million people, has invested $200 million to buy 10 million doses of the Russian vaccine.

The crisis-stricken OPEC nation also received 500,000 doses of China's Sinopharm COVID-19 vaccine earlier this week. Maduro said the government would begin to inoculate Venezuelans with the Sinopharm vaccine beginning on Monday.

Venezuela has reported 141,356 cases of the novel coronavirus and 1,371 deaths, well below levels of its South American peers. Many opposition politicians and medical personnel question those statistics, saying the true toll is likely far higher due to a lack of testing.

3rd party Ad. Not an offer or recommendation by Investing.com. See disclosure here or remove ads .

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.